ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Joaquı́n Mateo, Debyani Chakravarty, Rodrigo Dienstmann et al. · Annals of Oncology · 2018 · 787 citations · Full text

Medicine, Molecular Genetics, Oncology +17

ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe

Nathan I. Cherny, Richard Sullivan, Julie Torode et al. · Annals of Oncology · 2016 · 172 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacology +16

Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States

Andrew N. Freedman, Carrie N. Klabunde, Kristine Wiant et al. · JCO Precision Oncology · 2018 · 153 citations · Full text

Medicine, Oncology, Medical Oncology +11

Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities.

Chiara Di Resta, Silvia Galbiati, Paola Carrera et al. · PubMed · 2018 · 132 citations

Life Sciences, Bioinformatics, Genetics +17

ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe

Nathan I. Cherny, Richard Sullivan, Julie Torode et al. · Annals of Oncology · 2017 · 118 citations · Full text

Public Health, Oncology, Pharmaceutical Policy +13